-
September 6, 2005
Vanderbilt-Ingram Cancer Center offering cancer treatment for patients displaced by Hurricane Katrina
Cancer patients displaced by Hurricane Katrina and its aftermath who are in Middle Tennessee and Southern Kentucky and in need of continued treatment can contact the Vanderbilt-Ingram Cancer Center for assistance. -
June 15, 2005
Vanderbilt-Ingram Announces New Research Institute To Focus On Earliest Possible Detection Of Cancers
The Vanderbilt-Ingram Cancer Center will launch a new research institute, jump-started with a $10 million gift from West Tennessee businessman Jim Ayers, to develop techniques to detect cancers at their earliest, most curable stages, Vanderbilt officials announced today. -
August 7, 2003
Protein Profile Predicts Prognosis in Lung Cancer Patients
Researchers have moved a step closer to finding a "molecular fingerprint" of an individual's cancer. -
June 23, 2003
Migratory ability of cancer cells examined
Researchers are working to understand the process of how cancer cells develop the ability to migrate from their original location, settle and begin growing in another distant organ. -
June 17, 2003
Vanderbilt Psychiatrist Studying Fog Associated with Chemotherapy
Laurel Brown, PhD, assistant professor of psychiatry, is the principal investigator of a pilot study currently underway in The Vanderbilt Ingram Cancer Center, in conjunction with the Departments of Psychiatry and Psychology to uncover the cause of cognitive deficits many breast cancer patients experience after being treated with chemotherapy, often referred to as "chemo brain" or "chemo fog." -
June 12, 2003
Vanderbilt-Ingram researchers speak to world at national cancer conference
A team of Vanderbilt-Ingram Cancer Center physician-scientists gathered with their colleagues here earlier this week to hear, discuss and present some of the latest advances in care for patients with cancer. -
June 4, 2003
VICC offers new light therapy for esophageal, lung cancers
The Vanderbilt-Ingram Cancer Center is now offering a technique that uses a light-activated drug to help restore the ability to swallow in patients whose esophagus is blocked by cancer.